FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Neville Everett 2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2021 

3. Issuer Name and Ticker or Trading Symbol Cigna Corp [CI]
(Last)       (First)       (Middle)
900 COTTAGE GROVE ROAD
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
EVP, Strategy and Business Dev /
(Street)
BLOOMFIELD, CT 06002      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $.01 Par Value  7371.0000  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)  2/28/2016 (1) 3/4/2025  Common Stock, $.01 Par Value  192.0000  $176.6556  D   
Employee Stock Option (Right to Buy)  2/26/2021 (2) 2/26/2030  Common Stock, $.01 Par Value  8340.0000  $192.0200  D   
Phantom Stock Units (3)  (4)  (4) Common Stock, $.01 Par Value  418.6865 (3) $0.0000 (5) D   

Explanation of Responses:
(1)  This option is fully vested.
(2)  This option vests in three equal annual installments beginning February 26, 2021.
(3)  Phantom Stock Units credited under Express Scripts Executive Deferred Compensation Plan.
(4)  These Phantom Stock Units are fully vested.
(5)  Upon distribution, each Phantom Stock Unit converts to one share of Cigna Corporation Common Stock.

Remarks:
Exhibit 24 - Power of Attorney poaneville.txt

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Neville Everett
900 COTTAGE GROVE ROAD
BLOOMFIELD, CT 06002


EVP, Strategy and Business Dev

Signatures
By: Jill M. Stadelman, attorney-in-fact 1/8/2021
**Signature of Reporting Person Date